[PDF][PDF] STANDARDS OF PRACTICE

MA Chehab, A Thakor, S Tulin-Silver… - J Vasc Interv …, 2018 - academia.edu
SIR produces its Standards of Practice documents by using the following process. Topics of
relevance and timeliness are conceptualized by the Standards of Practice Committee …

Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies

LA Adang, O Sherbini, L Ball, M Bloom… - Molecular genetics and …, 2017 - Elsevier
Leukodystrophies are a broad class of genetic disorders that result in disruption or
destruction of central myelination. Although the mechanisms underlying these disorders are …

Placebo-controlled clinical trial of incobotulinumtoxinA for sialorrhea in children: SIPEXI

S Berweck, M Bonikowski, H Kim, M Althaus… - Neurology, 2021 - AAN Enterprises
Background and Objectives To investigate the efficacy and safety of repeated injections of
incobotulinumtoxinA (incoBoNT/A) for treatment of chronic sialorrhea (drooling) associated …

Botulinum toxin injections for treatment of drooling in children with cerebral palsy: a systematic review and meta-analysis

SA Hung, CL Liao, WP Lin, JC Hsu, YH Guo, YC Lin - Children, 2021 - mdpi.com
Background: We aimed to review and analyse the effectiveness and safety of botulinum
toxin type A (BoNT-A) injections for drooling in children with cerebral palsy. Data sources …

[HTML][HTML] Lacrimal and salivary gland ultrasound-how and when to use in patients with primary Sjögren's syndrome

V Fana, L Terslev - Best Practice & Research Clinical Rheumatology, 2023 - Elsevier
This paper addresses how to perform an ultrasound assessment of the salivary and lacrimal
glands, how to identify pathological changes, and how to score disease activity, focusing on …

Botulinum toxin A in the management of pediatric sialorrhea: a systematic review

T Heikel, S Patel, K Ziai, SJ Shah… - Annals of Otology …, 2023 - journals.sagepub.com
Objective: Botulinum toxin A is known to be effective and safe in managing sialorrhea in
pediatric patients; however, there is no consensus on a protocol for optimal injection sites …

Complex care of individuals with multiple sulfatase deficiency: Clinical cases and consensus statement

R Ahrens-Nicklas, L Schlotawa, A Ballabio… - Molecular genetics and …, 2018 - Elsevier
Multiple sulfatase deficiency (MSD) is an ultra-rare neurodegenerative disorder that results
in defective sulfatase post-translational modification. Sulfatases in the body are activated by …

Comparing the evidence for botulinum neurotoxin injections in paediatric anterior drooling: a scoping review

LB Orriëns, K van Hulst, JJW van der Burg… - European Journal of …, 2024 - Springer
Paediatric anterior drooling has a major impact on the daily lives of children and caregivers.
Intraglandular botulinum neurotoxin type-A (BoNT-A) injections are considered an effective …

BOTOX-A injection of salivary glands for drooling

A Alvarenga, M Campos, M Dias, L Melão… - Journal of pediatric …, 2017 - Elsevier
Background and purpose Drooling is a challenging entity to manage. Botulinum toxin A
(BOTOX-A) infiltration of salivary glands is a promising alternative to surgical treatment. This …

A consensus statement on the use of botulinum toxin in pediatric patients

JA Vova, MM Green, JE Brandenburg, L Davidson… - PM&R, 2022 - Wiley Online Library
Botulinum toxin has been used in medicine for the past 30 years. However, there continues
to be controversy about the appropriate uses and dosing, especially in the pediatric …